We are live on ! Find out more
Mawer Investment Management

Mawer Investment Management Portfolio holdings

AUM $14.7B
1-Year Est. Return 12.5%
This Fund
S&P 500
This Quarter Est. Return
+8.9%
1 Year Est. Return
+12.5%
3 Year Est. Return
+48.6%
5 Year Est. Return
+72.73%
10 Year Est. Return
+305.03%
AUM
$19.5B
AUM Growth
+$812M
Cap. Flow
-$649M
Cap. Flow %
-3.32%
Top 10 Hldgs %
46.76%
Holding
114
New
10
Increased
35
Reduced
59
Closed
7

Top Buys

Rank Stock Value
1
SHEL icon
Shell
SHEL
+$58.1M
2
ABT icon
Abbott
ABT
+$49.9M
3
ABBV icon
AbbVie
ABBV
+$43.3M
4
EL icon
Estee Lauder
EL
+$38M
5
RHI icon
Robert Half
RHI
+$25.6M

Sector Composition

Rank Sector Weight
1 Financials 29.39%
2 Technology 21.03%
3 Industrials 15.14%
4 Healthcare 13.86%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMG icon
76
Warner Music
WMG
$13.1B
$26.6M 0.14%
741,859
-3,646
-0.5% -$120K
GOOGL icon
77
Alphabet (Google) Class A
GOOGL
$4.2T
$7.85M 0.04%
56,165
-1,242
-2% -$167K
CRL icon
78
Charles River Laboratories
CRL
$13.5B
$6.15M 0.03%
26,025
+7,014
+37% +$1.38M
VVV icon
79
Valvoline
VVV
$4.21B
$5.68M 0.03%
151,116
+46,188
+44% +$1.55M
HUM icon
80
Humana
HUM
$44.8B
$5.5M 0.03%
12,023
+985
+9% +$486K
CNXC icon
81
Concentrix
CNXC
$1.57B
$5.12M 0.03%
52,127
+3,908
+8% +$340K
SN icon
82
SharkNinja
SN
$26.4B
$4.81M 0.02%
94,006
+70,019
+292% +$3.2M
EEFT icon
83
Euronet Worldwide
EEFT
$2.64B
$4.69M 0.02%
46,213
+18,262
+65% +$1.56M
ULTA icon
84
Ulta Beauty
ULTA
$23.3B
$4.3M 0.02%
+8,774
New +$3.7M
FCNCA icon
85
First Citizens BancShares
FCNCA
$25.4B
$4.09M 0.02%
2,881
+581
+25% +$816K
CBRE icon
86
CBRE Group
CBRE
$42.7B
$3.86M 0.02%
41,494
+3,404
+9% +$265K
RBA icon
87
RB Global
RBA
$16.6B
$3.81M 0.02%
56,924
+4,670
+9% +$300K
RMD icon
88
ResMed
RMD
$32.6B
$3.8M 0.02%
+22,090
New +$3.39M
KLAC icon
89
KLA
KLAC
$262B
$3.72M 0.02%
64,010
+5,190
+9% +$270K
CACI icon
90
CACI
CACI
$14.8B
$3.49M 0.02%
10,774
+884
+9% +$287K
LPLA icon
91
LPL Financial
LPLA
$29.2B
$3.37M 0.02%
+14,827
New +$3.33M
MOS icon
92
The Mosaic Company
MOS
$7.34B
$3.34M 0.02%
+93,395
New +$3.3M
MELI icon
93
Mercado Libre
MELI
$98.4B
$3.31M 0.02%
2,106
CSW
94
CSW Industrials
CSW
$5.72B
$3.22M 0.02%
15,504
-4,447
-22% -$807K
CSL icon
95
Carlisle Companies
CSL
$15.5B
$3.17M 0.02%
+10,160
New +$2.8M
FERG icon
96
Ferguson
FERG
$48.7B
$3.17M 0.02%
+16,436
New +$2.77M
PPLI
97
People Inc
PPLI
$2.97B
$3.07M 0.02%
71,415
-27,237
-28% -$1.07M
MORN icon
98
Morningstar
MORN
$7.33B
$2.5M 0.01%
8,736
+716
+9% +$187K
ORLY icon
99
O'Reilly Automotive
ORLY
$74.9B
$2.49M 0.01%
39,360
+3,240
+9% +$205K
MSCI icon
100
MSCI
MSCI
$40.8B
$2.32M 0.01%
4,106
+335
+9% +$173K

Similar funds

Mawer Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Mawer Investment Management held 114 positions worth $19.5B, up 4.3% from $18.7B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Mawer Investment Management withdrew a net $649M in Q4 2023, closing 7 positions and reducing 59 holdings. Its most notable exit was Organon & Co, an estimated $223M position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Mawer Investment Management opened a new position in AbbVie worth $46.1M.

  • Mawer Investment Management's largest Q4 2023 buy was AbbVie: 297,227 shares worth $46.1M.
  • Mawer Investment Management added most to Shell in Q4 2023, an estimated $58.1M increase.
  • Mawer Investment Management's biggest Q4 2023 reduction was Kenvue, cutting an estimated $138M.
  • Mawer Investment Management fully exited Organon & Co in Q4 2023, selling an estimated $223M.
  • Mawer Investment Management's ten largest holdings make up 47% of its $19.5B portfolio in Q4 2023.
  • Mawer Investment Management opened 10 new positions and closed 7 in Q4 2023.
  • Mawer Investment Management's portfolio value rose 4.3% quarter-over-quarter to $19.5B.

Based on Mawer Investment Management's 13F filing for Q4 2023, filed 7 Feb 2024.